Alzheon Appoints Renowned Industry Leader, Jean-Pierre Sommadossi, PhD, To Board Of Directors
8/5/2014 10:01:58 AM
Alzheon, Inc., a clinical-stage biopharmaceutical company focused on brain health, memory and aging, announced today that it has appointed Jean-Pierre Sommadossi, PhD, to the company’s Board of Directors. With more than 20 years of scientific, operational, strategic and management experience in the biotechnology industry, Dr. Sommadossi brings a seasoned and unique perspective to support Alzheon’s continued growth and advancement as a leading clinical-stage Alzheimer’s company.
Help employers find you! Check out all the jobs and post your resume.
comments powered by